HCV/Sindbis chimeric viruses to study the NS3 protease of hepatitis C virus in living cells

被引:0
|
作者
Filocamo, G [1 ]
Pacini, L [1 ]
Migliaccio, G [1 ]
机构
[1] IRBM P ANGELETTI,ROME,ITALY
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:3460 / 3460
页数:1
相关论文
共 50 条
  • [1] Chimeric sindbis viruses dependent on the NS3 protease of hepatitis C virus
    Filocamo, G
    Pacini, L
    Migliaccio, G
    JOURNAL OF VIROLOGY, 1997, 71 (02) : 1417 - 1427
  • [2] Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses
    Filocamo, G
    Pacini, L
    Nardi, C
    Bartholomew, L
    Scaturro, M
    Delmastro, P
    Tramontano, A
    De Francesco, R
    Migliaccio, G
    JOURNAL OF VIROLOGY, 1999, 73 (01) : 561 - 575
  • [3] Development of hepatitis C virus (HCV) chimeric replicons for identifying broad spectrum NS3 protease inhibitors
    Binder, Joseph
    Tetangco, Selwyna
    Wick, Megan
    Maegley, Karen
    Lingardo, Laura
    Patick, Amy
    Smith, George
    ANTIVIRAL RESEARCH, 2007, 74 (03) : A38 - A38
  • [4] Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease
    Mukhametov, Azat
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (12) : 1351 - 1361
  • [5] ASUNAPREVIR HCV Serine Protease NS3 Inhibitor Treatment of Hepatitis C Virus
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (04) : 247 - 254
  • [6] Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domain
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad-Ur
    Durdagi, Serdar
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 101
  • [7] Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir
    Berger, Kristi L.
    Triki, Ibtissem
    Cartier, Mireille
    Marquis, Martin
    Massariol, Marie-Josee
    Boecher, Wulf O.
    Datsenko, Yakov
    Steinmann, Gerhard
    Scherer, Joseph
    Stern, Jerry O.
    Kukolj, George
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 698 - 705
  • [8] Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease
    Chen, KX
    Njoroge, FG
    Prongay, A
    Pichardo, J
    Madison, V
    Girilavallabhan, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4475 - 4478
  • [9] Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection
    Mederacke, Ingmar
    Wedemeyer, Heiner
    Manns, Michael P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (02) : 181 - 189
  • [10] Hepatitis C virus NS3/4A protease
    Kwong, AD
    Kim, JL
    Rao, G
    Lipovsek, D
    Raybuck, SA
    ANTIVIRAL RESEARCH, 1998, 40 (1-2) : 1 - 18